Vladimir Tesar

Prof. Vladimir Tesar, MD, PhD, MBA, FERA, FASN
Head, Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague

2008–2014 – member of the Scientific Advisory Board of ERA-EDTA

2011–2014 – member of the Council of ERA-EDTA

2015 – chair, Immunonephrology Working Group, ERA-EDTA

2014–2017, president, International Society of Blood Purification

1999–2004, 2010–2012 and 2017–2020, president, Czech Society of Nephrology

Since 2019 – member of the Council of the International Society of Nephrology, vice-chair CEE regional board, since 2021 member of the Executive Committee of ISN Council and the chair of the CEE board

Member of the board of KDIGO guidelines for glomerulonephritis 2021

Substantial part of the publications deals with diagnosis and treatment of glomerulonephritides, mainly ANCA-positive vasculitis and lupus nephritis, IgA and membranous nephropathy and FSGS, renal and renovascular hypertension, and autosomal dominant polycystic kidney disease (and other genetic diseases of the kidney) and cardiovascular complications of renal failure.

Publications- author or co-author of more than 400 publications according to Pubmed, including New England Journal of Medicine, Lancet, Journal of the American Medical Association, Annals of Internal Medicine, Nephrology, Dialysis, Transplantation, American Journal of Kidney Diseases, Kidney International, Rheumatology, Blood Purification, Kidney and Blood Pressure Research, Journal of Nephrology, Annals of Rheumatic Diseases, Journal of Hypertension, etc.

Science Citation Index more than 14 000, Hirsch index 48, editorial board: Nephrology, Dialysis, Transplantation, subject editor, Clinical Journal of the American Society of Nephrology

National coordinator and member of the steering committee of several large randomized controlled trials in patients with CKD (e.g. AURORA, SHARP), diabetic kidney disease (e.g. SONAR, CCX140), IgAN (e.g.NEPHIGAN, PROTECT, ARTEMIS), FSGS (DUET, DUPLEX), membranous nephropathy, ANCA-asociated vasculitis (e.g. CYCAZAREM, CYCLOPS, IMPROVE, MYCYC, RITUXVAS, CLEAR, PEXIVAS)

 

Organization of international congresses

1999 – president of the 17^th Annual Meeting of the International Society of Blood Purification

2003 – president of the 11^th International ANCA and Vasculitis Workshop

2005 – president of the 6^th European Meeting on Peritoneal Dialysis

2007 – president of the 25^th Annual Meeting of the International Society of Blood Purification

2011 – president of the 48^th congress of the European Renal Association/European Dialysis and Transplantation Association

smaller meetings and educational courses: 3rd meeting of the International Federation of Kidney Foundations, meeting of the European Vasculitis Study Group, Nephrology Winter School (many times)

 

Clinical research not mentioned above

Founder and organizer of the Czech Registry of Renal Biopsies and the Czech National Registry of ANCA-associated vasculitis

Co-organizer of the large screening study of Fabry disease among the dialysis population in the Czech Republic

Organizer of several Czech cooperative studies in lupus nephritis and hypertension

 

EACCME Conflict of Interest Disclosure Form